Pacira BioSciences (PCRX) earnings, Oct 28, 2026: EPS −14%, stock −0.0%
In brief
Pacira BioSciences reported on Oct 28, 2026. Earnings per share changed −14% year over year, 17.9% below the estimate; revenue −2%. The stock opened with a −0.1% gap and closed the day −0.0% (Oct 28, 2026). The stock is now 0.6% below its 52-week high, +72.7% over 12 months. Next report: Nov 9, 2026.
EPS vs estimate−17.9%
EPS, YoY−14%
Revenue, YoY−2%
Gap · day−0.1% · −0.0%
EPS growth by quarter, YoY
Price reaction to earnings
| Report | Gap | Day |
|---|---|---|
| Aug 4, 2026 | −5.6% | −10.0% |
| Oct 28, 2026 | −0.1% | −0.0% |
Next-quarter estimates, ratings and the PCRX chart are in the terminal.
Open the terminalFAQ
When is Pacira BioSciences's next earnings report?
Nov 9, 2026. The date comes from daily data and is corrected if the company moves it.
How did Pacira BioSciences stock react to the report?
Opening gap −0.1%, day's result −0.0%.
Did Pacira BioSciences's earnings grow?
Earnings per share fell 14% year over year.
What is an earnings gap?
The jump between the close before and the open after the report. A big gap up often means large buyers are revaluing the company.